Alpha-galactosidase - PDFSEARCH.IO - Document Search Engine

Alpha-galactosidase
Results: 28

#	Item
21	APPROVAL OF REPLAGAL™ WITH CONDITIONS Conditional marketing approval has been granted for Replagal™ for the following indications: Replagal shows promising preliminary evidence of efficacy for the treatment of patien Add to Reading List Source URL: www.hc-sc.gc.ca Language: English - Date: 2013-07-12 14:26:09 Fabry disease Alpha-galactosidase Enzyme replacement therapy Methadone Eptifibatide Treprostinil Chemistry Health Medicine
22	State of Vermont Department of Vermont Health Access 312 Hurricane Lane, Suite 201 Williston, VT[removed]www.dvha.vermont.gov Add to Reading List Source URL: dvha.vermont.gov Language: English - Date: 2014-03-05 14:59:41 Healthcare reform in the United States Presidency of Lyndon B. Johnson Alpha-galactosidase Enzymes Galactosides Fabry disease Medicaid Medical necessity Gonadotropin-releasing hormone Health Medicine Federal assistance in the United States
23	Genzyme Corporation 500 Kendall Street Cambridge, MA[removed]T[removed]November 11, 2009 Add to Reading List Source URL: www.fda.gov Language: English Unit operations Orphan drugs Genzyme Sanofi Imiglucerase Alglucosidase alfa Respirator Syringe filter Alpha-galactosidase Chemistry Pollution Technology
24	Conditional Approval of Replagal™ (agalsidase alfa) Fact Sheet What is Replagal™ (agalsidase alfa)? Add to Reading List Source URL: www.hc-sc.gc.ca Language: English - Date: 2013-07-12 14:26:09 Alpha-galactosidase Medicine Enzyme replacement therapy Health Rare diseases Fabry disease
25	CFA Members GenzymeShortage Add to Reading List Source URL: www.fabrycanada.com Language: English - Date: 2012-02-26 16:46:11 Fabry disease Alpha-galactosidase Genzyme Enzyme replacement therapy Amyotrophic lateral sclerosis Rare diseases Health Lipid storage disorders
26	United States Court of Appeals For the First Circuit No[removed]IN RE: GENZYME CORP. SECURITIES LITIGATION, Add to Reading List Source URL: www.courthousenews.com Language: English - Date: 2014-06-10 11:20:05 Pharmaceutical sciences Genzyme Sanofi Orphan drugs Glycogen storage disease type II Alglucosidase alfa Prescription Drug User Fee Act Imiglucerase Alpha-galactosidase Medicine Health Food and Drug Administration
27	Waldek and Feriozzi BMC Nephrology 2014, 15:72 http://www.biomedcentral.com[removed] Add to Reading List Source URL: www.ncbi.nlm.nih.gov Language: English Kidney diseases Organ failure Nephrology Fabry disease Chronic kidney disease Renal function Renal failure Alpha-galactosidase Proteinuria Medicine Health Anatomy
28	Surgical management of Diabetic foot ulcers: A Tanzanian university teaching hospital experience Add to Reading List Source URL: www.ncbi.nlm.nih.gov Language: English Biology Fabry disease Alpha-galactosidase Point mutation Mutation Robert J. Desnick Rare diseases Health Lipid storage disorders